View:
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
May 8, 2001
- ------------------
(Date of earliest event reported)
LABORATORY CORPORATION OF AMERICA HOLDINGS
- ------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 1-11353 13-3757370
-------------- ----------- --------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
- -------------------------------------------------------
(Address of principal executive offices)
336-229-1127
- ------------
(Registrant's telephone number, including area code)
ITEM 9. Regulation FD Disclosure.
Laboratory Corporation of America -Registered Trademark-
Holdings (LabCorp -Registered Trademark-)(NYSE:LH) announced
that Thomas P. Mac Mahon, chairman and chief executive officer,
is scheduled to speak at the Deutsche Banc Alex. Brown Health
Care Conference in Baltimore, MD on Tuesday May 8, 2001. The
presentation will be webcast live at 4:30 p.m. Eastern Time,
with a rebroadcast available for 90 days, and may be heard
online at www.labcorp.com or www.db.com/conferences.
At the conference, Mr. Mac Mahon will reiterate Company
guidance for 2001 and 2002, as filed in an 8K on April 23, 2001.
Mr. Mac Mahon will state, "For 2001, we expect revenue growth of
11 percent, with a bad debt rate of 9.7 percent of sales, EBITDA
margins of approximately 21 percent of sales, and EPS growth of
approximately 50 percent. For 2002, we expect to increase
overall revenues in approximately the same range as for 2001,
and we expect EPS growth of approximately 30 percent compared to
2001".
The statements in this report which are not historical facts
or information may be forward-looking statements. These
forward-looking statements involve risks and uncertainties that
could cause the outcome to be materially different. Certain of
these risks and uncertainties are listed in the Laboratory
Corporation of America-registered trademark-Holdings 2000 Form
10-K and subsequent filings.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange
Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Registrant)
By:/s/ BRADFORD T. SMITH
----------------------------------
Bradford T. Smith
Executive Vice President,
General Counsel, Secretary
and Compliance Officer
Date: May 8, 2001